Surface roughness mediates its effects on osteoblasts via protein kinase A and phospholipase A2

被引:117
作者
Boyan, BD
Sylvia, VL
Liu, YH
Sagun, R
Cochran, DL
Lohmann, CH
Dean, DD
Schwartz, Z
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Orthopaed, San Antonio, TX 78229 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Periodont, San Antonio, TX 78229 USA
[3] Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA
[4] Wilford Hall USAF Med Ctr, Lackland AFB, TX 78236 USA
[5] Univ Gottingen, Dept Orthopaed, D-3400 Gottingen, Germany
[6] Hebrew Univ Jerusalem, Hadassah Fac Dent Med, Jerusalem, Israel
关键词
protein kinase A; PKA; phospholipase A(2); PLA(2); surface roughness; osteoblasts; MG63; cells; titanium; 1,25-(OH)(2)D-3;
D O I
10.1016/S0142-9612(99)00159-3
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Earlier studies have shown that implant surface roughness influences osteoblast proliferation, differentiation, matrix synthesis and local factor production. Moreover, the responsiveness of osteoblasts to systemic hormones, such as 1,25-(OH)(2)D-3, at the implant surface is also influenced by surface roughness and this effect is mediated by changes in prostaglandins. At present, it is not known which signaling pathways are involved in mediating cell response to surface roughness and how 1,25-(OH)(2)D-3 treatment alters the activation of these pathways. This paper reviews a series of studies that have addressed this question. MG63 osteoblast-like cells were cultured on commercially pure titanium (cpTi) surfaces of two different roughnesses (R-a 0.54 and 4.92 mu m) in the presence of control media or media containing 1,25-(OH)(2)D-3 or 1,25-(OH)(2)D-3 plus H8 (a protein kinase A inhibitor) or quinacrine (a phospholipase A(2) inhibitor). At harvest, the effect of these treatments on cell number and alkaline phosphatase specific activity was measured. Compared to cultures grown on the smooth surface, cell number was reduced on the rough surface. 1,25-(OH)(2)D-3 inhibited cell number on both surfaces and inhibition of protein kinase A in the presence of 1,25-(OH)(2)D-3 restored cell number to that seen in the control cultures. Inhibition of phospholipase A(2) in the presence of 1,25-(OH)(2)D-3 caused a further reduction in cell number on the smooth surface, and partially reversed the inhibitory effects of 1,25-(OH)(2)D-3 on the rough surface. Alkaline phosphatase specific activity was increased in cultures grown on the rough surface compared with those grown on the smooth surface; 1,25-(OH)(2)D-3 treatment increased enzyme specific activity on both surfaces. Cultures treated with H8 and 1,25-(OH)(2)D-3 displayed enzyme specific activity that approximated that seen in control cultures. Inhibition of phospholipase A(2) also inhibited the 1,25-(OH)(2)D-3-dependent effect on the smooth surface, but on the rough surface there was an inhibition of the 1,25-(OH)(2)D-3 effect as well as a partial inhibition of the surface roughness-dependent effect. The results indicate that surface roughness and 1,25-(OH)(2)D-3 mediate their effects through phospholipase A(2), which catalyzes one of the rate-limiting steps in prostaglandin E-2 production. Further downstream, prostaglandin E-2 activates protein kinase A. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2305 / 2310
页数:6
相关论文
共 43 条
  • [1] BINDING CHARACTERISTICS OF A MEMBRANE-RECEPTOR THAT RECOGNIZES 1ALPHA,25-DIHYDROXYVITAMIN D-3 AND ITS EPIMER, 1-BETA,25-DIHYDROXYVITAMIN D-3
    BARAN, DT
    RAY, R
    SORENSEN, AM
    HONEYMAN, T
    HOLICK, MF
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 56 (04) : 510 - 517
  • [2] Batzer R, 1998, J BIOMED MATER RES, V41, P489
  • [3] THE EFFECT OF GLASS-CERAMIC BONE IMPLANT MATERIALS ON THE INVITRO FORMATION OF HYDROXYAPATITE
    BLUMENTHAL, NC
    POSNER, AS
    COSMA, V
    GROSS, U
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1988, 22 (11): : 1033 - 1041
  • [4] STIMULATION OF MATRIX VESICLE ENZYME-ACTIVITY IN OSTEOBLAST-LIKE CELLS BY 1,25(OH)2D3 AND TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA)
    BONEWALD, LF
    SCHWARTZ, Z
    SWAIN, LD
    BOYAN, BD
    [J]. BONE AND MINERAL, 1992, 17 (02): : 139 - 144
  • [5] Boyan B. D., 1997, Vitamin D., P395
  • [6] Boyan BD, 1995, CELL MATER, V5, P323
  • [7] Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO
  • [8] 2-L
  • [9] Boyan BD, 1998, J CELL PHYSIOL, V176, P516, DOI 10.1002/(SICI)1097-4652(199809)176:3<516::AID-JCP8>3.0.CO
  • [10] 2-R